JAC Supplement: Survey of Antibiotic Resistance (SOAR) results 4—respiratory pathogen susceptibility
Alan Johnson, Jean-Yves Madec, Spyros Pournaras
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPneumonia and Respiratory Infections · Antibiotic Use and Resistance · Nosocomial Infections in ICU
Foreword
Community-acquired respiratory tract infections (CA-RTIs) continue to pose a major global health challenge. Development of local or national treatment guidelines should ideally take account of rates of antimicrobial resistance in bacterial pathogens associated with CA-RTIs. However, such data are often not readily accessible. To help address this issue, the Survey of Antibiotic Resistance (SOAR), an international antimicrobial resistance surveillance programme, was established in 2002. SOAR collects data on the susceptibility of two key respiratory pathogens, namely, Streptococcus pneumoniae and Haemophilus influenzae, with a focus on countries where susceptibility data from other sources are not always widely available.
This Supplement provides an update on international surveillance data for resistance in S. pneumoniae and H. influenzae previously published in the Supplements of the Journal of Antimicrobial Chemotherapy in 2016, 2018 and 2020. In a series of eight articles, data are made available for countries in Europe (Italy, Spain, Ukraine), North Africa (Tunisia) and Asia (India, Kuwait, Pakistan, Turkey, the United Arab Emirates, Vietnam). Important resistance issues were observed among S. pneumoniae in several countries, commonly affecting oral/low-dose penicillin, while H. influenzae exhibited overall higher susceptibilities for most antibiotics except trimethoprim/sulfamethoxazole. Studies such as these are important in providing greater insight into the epidemiology of antimicrobial resistance over time at both a national and international level and guiding empiric therapy of infections.
We thank the authors for their contributions to this Supplement. Given the global scale of the threat posed by antibiotic resistance, it is hoped that the articles herein will be of interest to healthcare professionals, researchers, policymakers and others engaged in efforts to ensure bacterial infections remain treatable.